CureVac NV (5CV) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.02x

CureVac NV (5CV) has a Cash Flow Reinvestment Rate of 0.02x as of September 2025, reinvesting €644.00K (capex €322.00K plus investments €-322.00K) from operating cash flow of €29.86 Million. Check cash flow quality index of CureVac NV to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.02x
(Capex + Investments) / Operating CF

Total Reinvested

€644.00K
Capex + Investments

Operating Cash Flow

€29.86 Million
EUR

Capital Expenditures

€322.00K
EUR

CureVac NV Cash Flow Reinvestment Rate (2020–2024)

Historical reinvestment intensity for CureVac NV across 2 annual periods. Explore CureVac NV debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for CureVac NV (2020–2024)

Year-by-year capital reinvestment analysis for CureVac NV. For live market cap and broader valuation context, see CureVac NV (5CV) total market value.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 0.36x €36.89 Million €101.85 Million €18.44 Million ▲ +404.7%
2020 0.07x €37.49 Million €522.40 Million €36.33 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow